Pulmonology Software Market Synopsis

Pulmonology Software Market Size Was Valued at USD 1.4 Billion in 2023 and is Projected to Reach USD  3.44 Billion by 2032, Growing at a CAGR of 10.5% From 2024-2032.
Pulmonology is a branch of medicine concerned with diseases and disorders of the respiratory system and there is specific software called pulmonology software, which is digital tools used by pulmonologists, respiratory therapists and other care givers. Integrated electronic health record (EHR), pulmonary function test (PFT) analysis, imaging review, treatment planning and patient outcome have been noticed in this software. Thus pulmonology software seeks to make actual change and advance the process of decision making basis on clinical evidence, patient evaluation and the provision of respiratory care.

• Utilizing a case study of pulmonology software, the market analysis revealed that market has expanded in the past few years owing to several factors among which include advanced technology, rising cases of pulmonary diseases, and the need to adopt shared software solutions. Pulmonology software can be defined as software solutions mainly developed to support respiratory physicians and respiratory therapists in the diagnosis, therapy as well as management of respiratory diseases including asthma, chronic obstructive pulmonary diseases, or sleep disorders.
• The opportunities that are observed in this market: The technological advancement is one of the most influential and significant growth contributing factors in the pulmonology software market. Technological advancement the next generation electronic health records (EHRs), telemedicine platforms, and mobile health application revolutionized Respiratory Care practice. These technologies assist the pulmonologists to be in a position to access patient’s details from the comfort of their home, work in agreement with other doctors and be in a position to attend to patients as required and this will improve the lives of patients as well as decrease the amount of money spent on health bills.
• Moreover, the rising incidence of respiratory disorders across the globe also contributes to the economic benefits of implementing pulmonology software systems. The WHO Global Burden of Disease report has shown that respiratory diseases are among the major health system burdens and key contributors to morbidity and mortality in the current world, with examples including COPD, asthma and respiratory tract infections. This above trend shows that management of respiratory diseases is on the rise, thus the need for pulmonology software to ensure that respiratory diseases among individuals are effectively managed by the healthcare providers.
• Furthermore, the migrating trend towards the value-based care and focuses on the population health have worked in favour of the application of pulmonology software. Bed reductions and the allocation of a greater proportion of resources to deliver care to patients in different settings, outside of the hospital are creating more emphasis. Pulmonology software solutions allow the use of care coordination tools, patient educational tools, and even population health analytics that help integrated care delivery and more proactive and personalised respiratory care.
• Additionally, recent years have been marked by the continual growth of the pulmonology software market due to the growing number of patients suffering from respiratory diseases and the COVID-19 pandemic. Video consultation applications and distance monitoring devices emerged as vital instruments for managing respiratory patients while avoiding infection spreading. Therefore, most of the healthcare facilities decided to implement pulmonology software in their working processes to enhance telehealth.
• Incidence and increases of, as well as variability of, disease and conditions in today’s population, and advancements in and trends of the healthcare systems. However, some factors, including the dispute of data security, compatibility and restrictions of the laws governing the market, might act as constraints towards market growth. However, proper approaches and solutions should be implemented; thus, pulmonology software vendors should take the defined opportunity and match the need in respiratory care solutions while enhancing patient experiences in the following years.

Pulmonology Software Market Trend Analysis

Telemedicine and Remote Patient Monitoring Solutions for Pulmonary Care:

• Having discussed the current approaches that include telemedicine and remote patient monitoring (RPM) is transforming pulmonary care through efficient and accessible solutions. Telemedicine helps patient schedule an appointment with pulmonologists via technology which is helpful for those who cannot easily make it to appointments due to living in rural areas or those that have limited access to health care services. By using video calls and online platforms, the pulmonologists can evaluate the patients’ conditions and consequently suggest adjustments to prescriptions and diets or provide advice on proper medication usage, which, in turns, may help patients avoid unnecessary clinic visits thus decreasing the re-admission rate. Moreover, applications of RPM, including wearables and applications, challenge healthcare consumers to manage different aspects of their respiratory health at home. They monitor parameters such as oxygen levels and lung activity to identify any early sign of worsening and consequently provide timely intercession which in effect increases the patients’ quality of life and decreases the overall health expenditures inherent to uncontrolled hospital admittances.
• Also, the use of telemedicine as well as RPM does not only improve the treatment delivery but also increases efficiency in care delivery for pulmonologists. Remote monitoring means that clinicians can monitor patients’ exacerbations of pulmonary conditions and introduce interventions in cases of deviation from normal range, thereby averting deterioration and adversities. In addition, telemedicine policies enhance interdisciplinary relationships, which means that pulmonologist can communicate with other specialist including cardiologist, or sleep disorder physicians for the overall management of patients with severe respiratory related diseases.

Personalized Treatment Algorithms

• Current Approaches: This is enhancing pulmonary care through the use of effective and easily accessible solutions such as telemedicine, and remote patient monitoring (RPM). Telemedicine makes it easier for patient to have an appointment with pulmonologist through technology especially when the patient cannot go to most appointments due to lack of transport, being in rural areas or having health limitation to access health services. Hence, the pulmonologists can work through video calls or use platforms and assess the patients’ status, and, therefore, recommend changes to prescriptions and diets or given necessary instructions on taking medicines, which in return may possibly reduce the number of clinic visits or admission rates. Furthermore, applications of RPM such as wearables and apps also endeavor to put pressure on healthcare consumers to independently segment several aspects of respiratory health at their home. They constantly observe signs like oxygen requirements, lung movements and any indication of deterioration and then promptly intervene which in turn enhance patient’s quality of life and reduces total health care costs associated with hospitalizations that would otherwise remain untamed if observed and hence the need for a surveillance system.
• Leveraging telemedicine or RPM not only enhances the treatment and management processes, but it also helps pulmonists to provide more efficient care. Observational telemedicine means that clinicians can observe patients’ conditions of pulmonary nature dilating and initiate interventional measures whenever the deviation from range indicates deterioration and adverse outcomes. Besides, telemedicine policies help in building interdisciplinary relations and in this way, a pulmonologist is able to share common discussion with other specialists, for instance a cardiologist or a sleep disorders physician concerning the overall management of patients with severe respiratory related conditions.

Pulmonology Software Market  Analysis:

Pulmonology Software Market  Segmented based on  By Type, and  By Application.

By Type, Measurement Software  segment is expected to dominate the market during the forecast period

• Pulmonology and software solutions are crucial tools that help immensely in diagnosing respiratory ailments, administering treatment, and monitoring patient care. Measurement software has been provided to enable accurate measurements of various factors including lung capacity, the level of resistance in the airways, and the efficiency of the gas exchange. These applications contribute to accurate and efficient assessment of the patients’ conditions, useful in observing disease advancement and treatment outcomes among medical practitioners. Measurement software also helps clinicians gather and analyze data more efficiently in order to help them in their decision making processes while also facilitating better coordination of patient therapy and management to enhance treatment as well as the quality of care in pulmonology.
• While analysis software makes use of higher level algorithms and data visualization tools in order to derive some useful information out of the growing volumes of medical data. They also offer the means of studying in detail the patterns of respiratory illnesses and possible causes, as well as making accurate predictions about the future. Subsequently, analysis software exposes underlying relationships in large data sets, contributing to more effective diagnostic ability, evidence-based medicine, and further investigation within the pulmonary specialty. In addition, efficient integrated with a management solution assists to automate administrative work, to improve communication between different healthcare providers, and to coordinate the work of the multi-professional team, as well as to improve the efficiency of processes and health care delivery in the field of pulmonology.

 By Application , Hospital segment held the largest share in 2023

• The market of Pulmonology Software is growing largely because it is useful in all the healthcare sectors: Hospitals, Clinics and Physical Examination Center. These software solutions provide numerous functionalities designed to address the various requirements of pulmonologists and respiratory care enthusiasts. Pulmonology software in hospitals enables the health care practitioners to optimally manage significant aspects of a patients’ care path including diagnosing and managing of lungs ailments. Clinics gain from these solutions due to securing of patient data for analysis, efficient respiratory assessment of the patients besides maximizing their operational efficiency. In addition, pulmonology software is incorporated into the physical examination center’s system to maximize the accurate diagnostic of respiratory diseases and timely treatment. Hence, the increasing requirement of organizations in providing specialized pulmonary care will accelerate the adoption of pulmonology software in these settings even further.
• As respiratory diseases are on the rise and technology is playing a great part in helping to develop better Pulmonology Software Market. These systems have enhanced functionalities like EHR integration, real-time analytical tools for disease diagnosis, and telemedicine that allow the provider’s delivery of remote effective care to patients. Moreover, the shift towards an individualized medicine and value based care delivery which are key uplift across pulmonary disorders diagnosis and treatment have also helped drive demand for pulmonology software for use in the development of tailored clinical and patient outreach strategies. In addition, running with the goal of achieving maximum resource utilization and minimum health care costs, the pulmonology software helps the healthcare organizations to improve the clinic practice in the most efficient way and also help in getting improved diagnosis and getting through with the principles of the law strictly. Due to constant advancements in technology and need for moving towards digital health solutions, the Pulmonology Software Market is expected to grow and develop further in worldwide market to fill the needs of the increasing number of pulmonologists and respiratory care providers.

Pulmonology Software Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• The above factors contribute to the realization of the fact that North America will lead the world in terms of market share in pulmonology software in the coming forecast period. Firstly, advanced medical field and the adoption of technology especially for medical software is high in the region. As the later part of this paper will demonstrate, North American based corporations are the most involved in R&D spending and pulmonology software is no exception as the industry constantly updates its products to fit modern clinical practice. Also, the increased rate of diseases including asthma, COPD, and lung cancer in North America has placed a demand on precise diagnosis, treatment, and management software in this health district. Thus, the market is expected to remain on the steady growth as more and more players from the healthcare sector switches to digital solutions in order to enhance their patient outcomes and organizational performance in North America.
• Its reimbursement policies that support the development of good solutions for pulmonology in healthcare organizations in North America are bolstered by an appropriate regulatory environment. Other developments include government agenda that support quest for EHRs and telemedicine that propel market progress by embracing pulmonology software into these frameworks. Furthermore, the collaborative efforts of software developers, medical and healthcare organizations, and academic institutions promote new product development and growth of this market. Increasing focus on preventing diseases through digital treatment and proper diagnosis along with the rising market trends of North America could potentially strengthen its position in the global pulmonology software.

Active Key Players in the Pulmonology Software Market

• Koninklijke Philips N.V. (Netherlands)
• 3M Health Information Systems (US)
• Cerner Corporation (US)
• Nuance Communications, Inc. (US)
• Health Fidelity (US)
• Optum, Inc. (US)
• ChartWise Medical Systems, Inc. (US)
• Dolbey Systems, Inc. (US)
• Streamline Healthcare Solutions, LLC (US)
• Other Key Players

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. PULMONOLOGY SOFTWARE MARKET BY  TYPE (2017-2032)
   1. PULMONOLOGY SOFTWARE MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3.  MEASUREMENT SOFTWARE
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. ANALYSIS SOFTWARE
   5. MANAGEMENT SOFTWARE
7. PULMONOLOGY SOFTWARE MARKET BY APPLICATION (2017-2032)
   1. PULMONOLOGY SOFTWARE MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. HOSPITAL
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. CLINIC
   5. PHYSICAL EXAMINATION CENTER
8. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. Pulmonology Software Market Share By Manufacturer (2023)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
   2. KONINKLIJKE PHILIPS N.V. (NETHERLANDS)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
   3. 3M HEALTH INFORMATION SYSTEMS (US)
   4. CERNER CORPORATION (US)
   5. NUANCE COMMUNICATIONS, INC. (US)
   6. HEALTH FIDELITY (US)
   7. OPTUM, INC. (US)
   8. CHARTWISE MEDICAL SYSTEMS, INC. (US)
   9. DOLBEY SYSTEMS, INC. (US)
   10. STREAMLINE HEALTHCARE SOLUTIONS, LLC (US)
9. GLOBAL PULMONOLOGY SOFTWARE MARKET BY REGION
   1. OVERVIEW
   2. NORTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By  Type
      4. Historic And Forecasted Market Size By Application
      5. Historic And Forecasted Market Size By Country
         1. USA
         2. Canada
         3. Mexico
   3. EASTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Russia
         2. Bulgaria
         3. The Czech Republic
         4. Hungary
         5. Poland
         6. Romania
         7. Rest Of Eastern Europe
   4. WESTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Germany
         2. United Kingdom
         3. France
         4. The Netherlands
         5. Italy
         6. Spain
         7. Rest Of Western Europe
   5. ASIA PACIFIC
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Malaysia
         6. Thailand
         7. Vietnam
         8. The Philippines
         9. Australia
         10. New-Zealand
         11. Rest Of APAC
   6. MIDDLE EAST & AFRICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Turkey
         2. Bahrain
         3. Kuwait
         4. Saudi Arabia
         5. Qatar
         6. UAE
         7. Israel
         8. South Africa
   7. SOUTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Brazil
         2. Argentina
         3. Rest of South America
10. INVESTMENT ANALYSIS
11. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. PULMONOLOGY SOFTWARE MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. PULMONOLOGY SOFTWARE MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. PULMONOLOGY SOFTWARE MARKET COMPETITIVE RIVALRY
TABLE 005. PULMONOLOGY SOFTWARE MARKET THREAT OF NEW ENTRANTS
TABLE 006. PULMONOLOGY SOFTWARE MARKET THREAT OF SUBSTITUTES
TABLE 007. PULMONOLOGY SOFTWARE MARKET BY TYPE
TABLE 008. MEASUREMENT SOFTWARE MARKET OVERVIEW (2016-2028)
TABLE 009. ANALYSIS SOFTWARE MARKET OVERVIEW (2016-2028)
TABLE 010. MANAGEMENT SOFTWARE MARKET OVERVIEW (2016-2028)
TABLE 011. PULMONOLOGY SOFTWARE MARKET BY APPLICATION
TABLE 012. HOSPITAL MARKET OVERVIEW (2016-2028)
TABLE 013. MARKET OVERVIEW (2016-2028)
TABLE 014. CLINIC MARKET OVERVIEW (2016-2028)
TABLE 015. MARKET OVERVIEW (2016-2028)
TABLE 016. PHYSICAL EXAMINATION CENTER MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA PULMONOLOGY SOFTWARE MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA PULMONOLOGY SOFTWARE MARKET, BY APPLICATION (2016-2028)
TABLE 019. N PULMONOLOGY SOFTWARE MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE PULMONOLOGY SOFTWARE MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE PULMONOLOGY SOFTWARE MARKET, BY APPLICATION (2016-2028)
TABLE 022. PULMONOLOGY SOFTWARE MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC PULMONOLOGY SOFTWARE MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC PULMONOLOGY SOFTWARE MARKET, BY APPLICATION (2016-2028)
TABLE 025. PULMONOLOGY SOFTWARE MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA PULMONOLOGY SOFTWARE MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA PULMONOLOGY SOFTWARE MARKET, BY APPLICATION (2016-2028)
TABLE 028. PULMONOLOGY SOFTWARE MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA PULMONOLOGY SOFTWARE MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA PULMONOLOGY SOFTWARE MARKET, BY APPLICATION (2016-2028)
TABLE 031. PULMONOLOGY SOFTWARE MARKET, BY COUNTRY (2016-2028)
TABLE 032. CLEVEMED: SNAPSHOT
TABLE 033. CLEVEMED: BUSINESS PERFORMANCE
TABLE 034. CLEVEMED: PRODUCT PORTFOLIO
TABLE 035. CLEVEMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. COMPUMEDICS: SNAPSHOT
TABLE 036. COMPUMEDICS: BUSINESS PERFORMANCE
TABLE 037. COMPUMEDICS: PRODUCT PORTFOLIO
TABLE 038. COMPUMEDICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. ELMIKO MEDICAL EQUIPMENT: SNAPSHOT
TABLE 039. ELMIKO MEDICAL EQUIPMENT: BUSINESS PERFORMANCE
TABLE 040. ELMIKO MEDICAL EQUIPMENT: PRODUCT PORTFOLIO
TABLE 041. ELMIKO MEDICAL EQUIPMENT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. INGMAR MEDICAL: SNAPSHOT
TABLE 042. INGMAR MEDICAL: BUSINESS PERFORMANCE
TABLE 043. INGMAR MEDICAL: PRODUCT PORTFOLIO
TABLE 044. INGMAR MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. MEDICAL EQUIPMENT EUROPE: SNAPSHOT
TABLE 045. MEDICAL EQUIPMENT EUROPE: BUSINESS PERFORMANCE
TABLE 046. MEDICAL EQUIPMENT EUROPE: PRODUCT PORTFOLIO
TABLE 047. MEDICAL EQUIPMENT EUROPE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. MEDISOFT GROUP: SNAPSHOT
TABLE 048. MEDISOFT GROUP: BUSINESS PERFORMANCE
TABLE 049. MEDISOFT GROUP: PRODUCT PORTFOLIO
TABLE 050. MEDISOFT GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. MICHIGAN INSTRUMENTS: SNAPSHOT
TABLE 051. MICHIGAN INSTRUMENTS: BUSINESS PERFORMANCE
TABLE 052. MICHIGAN INSTRUMENTS: PRODUCT PORTFOLIO
TABLE 053. MICHIGAN INSTRUMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. MORGAN SCIENTIFIC: SNAPSHOT
TABLE 054. MORGAN SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 055. MORGAN SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 056. MORGAN SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. NATUS MEDICAL INCORPORATED: SNAPSHOT
TABLE 057. NATUS MEDICAL INCORPORATED: BUSINESS PERFORMANCE
TABLE 058. NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 059. NATUS MEDICAL INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. NOX MEDICAL: SNAPSHOT
TABLE 060. NOX MEDICAL: BUSINESS PERFORMANCE
TABLE 061. NOX MEDICAL: PRODUCT PORTFOLIO
TABLE 062. NOX MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. VITALOGRAPH: SNAPSHOT
TABLE 063. VITALOGRAPH: BUSINESS PERFORMANCE
TABLE 064. VITALOGRAPH: PRODUCT PORTFOLIO
TABLE 065. VITALOGRAPH: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. PULMONOLOGY SOFTWARE MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. PULMONOLOGY SOFTWARE MARKET OVERVIEW BY TYPE
FIGURE 012. MEASUREMENT SOFTWARE MARKET OVERVIEW (2016-2028)
FIGURE 013. ANALYSIS SOFTWARE MARKET OVERVIEW (2016-2028)
FIGURE 014. MANAGEMENT SOFTWARE MARKET OVERVIEW (2016-2028)
FIGURE 015. PULMONOLOGY SOFTWARE MARKET OVERVIEW BY APPLICATION
FIGURE 016. HOSPITAL MARKET OVERVIEW (2016-2028)
FIGURE 017. MARKET OVERVIEW (2016-2028)
FIGURE 018. CLINIC MARKET OVERVIEW (2016-2028)
FIGURE 019. MARKET OVERVIEW (2016-2028)
FIGURE 020. PHYSICAL EXAMINATION CENTER MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA PULMONOLOGY SOFTWARE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE PULMONOLOGY SOFTWARE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC PULMONOLOGY SOFTWARE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA PULMONOLOGY SOFTWARE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA PULMONOLOGY SOFTWARE MARKET OVERVIEW BY COUNTRY (2016-2028)